Huntington's disease Trials in Cardiff, United Kingdom
Conditions / Huntington's disease / Cardiff, United Kingdom
Clinical trials for Huntington's disease investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02342548 | Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 | TERMINATED | PHASE2 |
| NCT00665223 | A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease | COMPLETED | PHASE3 |
| NCT01590589 | REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN) | COMPLETED | — |
| NCT05107128 | A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD) | COMPLETED | PHASE2 |
| NCT02855476 | HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease | RECRUITING | — |
| NCT02494778 | A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease | TERMINATED | PHASE2 |
| NCT01574053 | Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | RECRUITING | — |
| NCT02006472 | A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease | COMPLETED | PHASE2 |
| NCT05655520 | A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease | TERMINATED | PHASE3 |
| NCT02197130 | Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease | COMPLETED | PHASE2 |